Risk of Cardiovascular Implantable Electronic Device Infection in Patients With Cardiac Sarcoidosis
In this cohort of patients with cardiac sarcoidosis undergoing CIED implantation, immunosuppressive therapy at the time of implantation was not associated with an increased risk of device-related infection.
Authors
- Anjali Wagle (ORCID: https://orcid.org/0000-0002-6475-5774)
- Nisha A. Gilotra (ORCID: https://orcid.org/0000-0002-4511-8008)
- John D. Mitchell (ORCID: https://orcid.org/0000-0003-0045-2288)
- Chukwuka Ibecheozor
- Chloe Duvall (ORCID: https://orcid.org/0000-0002-8504-6985)
- Jonathan Chrispin (ORCID: https://orcid.org/0000-0002-7985-3019)
- Maryam M. Sani
Institutions
- Yale New Haven Hospital (US)
- NewYork–Presbyterian Hospital (US)
- Johns Hopkins University (US)
- University of Pittsburgh (US)
- Cornell University (US)
- Johns Hopkins Medicine (US)
- Presbyterian Hospital (US)
Publication Details
- Journal
- Journal of Cardiovascular Electrophysiology
- Published
- 2026-02-22
- DOI
- https://doi.org/10.1111/jce.70301
- Primary Topic
- Sarcoidosis and Beryllium Toxicity Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00